Related Experiment Video
Updated: May 7, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Screening for HIV-associated peripheral neuropathy in resource-limited settings
Deanna Cettomai1, Judith K Kwasa, Gretchen L Birbeck
1Department of Neurology, University of California San Francisco, 1001 Potrero Avenue, 4M62, Box 0870, San Francisco, California, 94110, USA.
Screening tools used by healthcare workers can effectively identify peripheral neuropathy in HIV patients in resource-limited settings. These tools show high accuracy, aiding in early diagnosis and management.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- Peripheral neuropathy is a common complication of Human Immunodeficiency Virus (HIV) infection.
- Under-diagnosis of neuropathy is prevalent in resource-limited settings.
- Effective screening tools are needed for early detection.
Purpose of the Study:
- To evaluate the utility of screening tools administered by nonphysician healthcare workers (HCW).
- To assess the role of quantitative sensory testing (QST) by trained staff.
- To identify moderate/severe neuropathy in HIV-infected outpatients.
Main Methods:
- 240 HIV-infected outpatients were enrolled using 2-stage cluster randomized sampling.
- HCWs administered various screening tools; trained staff performed QST.
- Tools were validated against clinical diagnosis of neuropathy.
Main Results:
- 18% of participants had moderate/severe neuropathy.
- Screening tests demonstrated 76% sensitivity and high negative predictive values (84-92%).
- QST showed lower sensitivity but higher specificity compared to screening tests.
Conclusions:
- Screening tests administered by HCWs are effective and promising for large-scale implementation.
- These tools can improve the diagnosis of peripheral neuropathy in resource-limited areas.
- QST is valuable for research purposes in diagnosing neuropathy.
Related Concept Videos
Diabetic Neuropathy
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease IV: Nursing Management

